Actively Recruiting
Baduanjin With Resistance Training Program for Elderly Patients With Osteoporosis and Lumbar Disc Herniation
Led by Yale University · Updated on 2025-11-21
110
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
Y
Yale University
Lead Sponsor
Y
Yale-China Association
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to improve symptoms in elderly patients with Lumbar Disc Herniation (LDH) and Osteoporosis (OP) by studying an evidence-based Baduanjin exercise program. The goal is to reduce pain, increase muscle strength, and enhance quality of life for Chinese patients with these conditions. This study provides new insights into exercise treatments for elderly patients with LDH and OP. Participants in the control group will continue their usual post-surgery care, which includes comprehensive care and educational materials about lumbar and back exercises. They will also participate in three interactive question-and-answer sessions before discharge. The experimental group will receive this usual care plus a Baduanjin exercise program combined with resistance training. This includes individual training sessions from admission to one week post-surgery, no training in week two, group sessions during weeks three to twelve, and independent exercise with a diary from weeks thirteen to twenty-four. Participants will be assessed through in-person visits at baseline and week one, followed by phone calls at weeks twelve and twenty-four. Researchers will measure changes in quality of life using the Oswestry Disability Index, muscle strength with the Five Times Sit-to-Stand Test, and physical activity levels via the International Physical Activity Questionnaire. They will also evaluate secondary outcomes such as exercise self-efficacy, perceived exercise benefits, and incidence of post-surgery complications.
CONDITIONS
Brief Title
Baduanjin With Resistance Training Program
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with Lumbar Disc Herniation and Osteoporosis based on clinical and chart criteria
- Female patients aged 45 years or older, male patients aged 50 years or older
- Pain level of 3 or higher on the Visual Analogue Scale
- Surgical operation planned within a 7-day admission period
- Ability to speak Mandarin
You will not qualify if you...
- Presence of severe primary diseases such as ulcerative colitis, gastrointestinal bleeding, pancreatitis, lung cancer, pneumonia, acute respiratory distress syndrome, psychosis, depression, anxiety, or substance abuse
- Engagement in regular aerobic physical activity (at least 30 minutes, 3 times per week) in the past 3 months
- Use of certain medications in the past 3 months, including bisphosphonates, glucocorticoids, calcitonin, anticonvulsants, or heparin
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 24 weeks
Participants undergo conventional post-surgery treatment, including educational handouts and three interactive Q&A sessions. Participants in the experimental group also participate in a Baduanjin with resistance training program consisting of individual and group sessions, followed by independent exercises with an exercise diary.
2 in-person visits at baseline and Week 1, plus phone calls at Week 12 and Week 24
Trial Site Locations
Total: 1 location
1
Second Xiangya Hospital
Changsha, Hunan, China
Actively Recruiting
Research Team
3
3. Soohyun Nam, PhD
T
Tieying Qiu, RN
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here